Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Board/Management Information 2018

Sep 7, 2018

60507_rns_2018-09-07_3a398412-ab59-4594-845a-46c9640216bb.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Pfizer Limited The Capital, 1802 / 1901 , Plot No. C - 70, G Block, Sandra Kurla Complex, Sandro (East). Mumbai 400 051 . Tel : +91 22 6693 2000 Fax: +91 22 2654 0274

September 7, 2018

The Corporate Relationship Dept. BSE Limited 1st Floor, P.J.Towers Dalal Street, Fort Mumbai - 400 001 Scrip Code: 500680

The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Continuation of the remaining term of Mr. R. A. Shah as an Independent Director up to November 9, 2019.

Pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Members at the 6th Annual General Meeting of the Company held on Thursday, September 6, 2018 have passed a special resolution for continuation of the remaining term of Mr. R. A. Shah as an Independent Director up to November 9, 2019 with the requisite majority.

We give below a brief profile of Mr. R. A. Shah.

Mr. R. A. Shah is the Chairman of the Company and a leading solicitor and a senior partner of M/s. Crawford Bayley & Co., a firm of advocates and Solicitors. Mr. Shah has substantial expertise and specializes in a broad spectrum of corporate laws with special focus on Foreign Investments, Joint Ventures, Technology and License Agreement, Intellectual Property Rights, Mergers and Acquisitions, Industrial Licensing, Anti-Trust Laws, Company Law and Taxation.

Mr. R. A. Shah is not related to any of the Directors of the Company. It is further informed that Mr. R. A. Shah is not debarred from holding the office of Director by virtue of any SEBI order and any such authority.

We request you to kindly take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

Cf-~ /. ~

Prajeet Nair Company Secretary

CIN : l t.231MH19SOPLC008311

~ [email protected]

0 www.pfizerindia.com